81 related articles for article (PubMed ID: 23301758)
1. miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling.
Momose K; Minami A; Shimono Y; Mizutani K; Nobutani K; Azuma T; Takai Y
Genes Cells; 2013 Mar; 18(3):195-202. PubMed ID: 23301758
[TBL] [Abstract][Full Text] [Related]
2. Reduction of the ST6 β-galactosamide α-2,6-sialyltransferase 1 (ST6GAL1)-catalyzed sialylation of nectin-like molecule 2/cell adhesion molecule 1 and enhancement of ErbB2/ErbB3 signaling by microRNA-199a.
Minami A; Shimono Y; Mizutani K; Nobutani K; Momose K; Azuma T; Takai Y
J Biol Chem; 2013 Apr; 288(17):11845-53. PubMed ID: 23504322
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Necl-4/CADM4 with ErbB3 and integrin α6 β4 and inhibition of ErbB2/ErbB3 signaling and hemidesmosome disassembly.
Sugiyama H; Mizutani K; Kurita S; Okimoto N; Shimono Y; Takai Y
Genes Cells; 2013 Jun; 18(6):519-28. PubMed ID: 23611113
[TBL] [Abstract][Full Text] [Related]
4. Silencing of ErbB3/ErbB2 signaling by immunoglobulin-like Necl-2.
Kawano S; Ikeda W; Kishimoto M; Ogita H; Takai Y
J Biol Chem; 2009 Aug; 284(35):23793-805. PubMed ID: 19561085
[TBL] [Abstract][Full Text] [Related]
5. Interaction of nectin-like molecule 2 with integrin alpha6beta4 and inhibition of disassembly of integrin alpha6beta4 from hemidesmosomes.
Mizutani K; Kawano S; Minami A; Waseda M; Ikeda W; Takai Y
J Biol Chem; 2011 Oct; 286(42):36667-76. PubMed ID: 21880726
[TBL] [Abstract][Full Text] [Related]
6. Necl-2/CADM1 interacts with ErbB4 and regulates its activity in GABAergic neurons.
Yamada A; Inoue E; Deguchi-Tawarada M; Matsui C; Togawa A; Nakatani T; Ono Y; Takai Y
Mol Cell Neurosci; 2013 Sep; 56():234-43. PubMed ID: 23769722
[TBL] [Abstract][Full Text] [Related]
7. Functional cooperation of miR-125a, miR-125b, and miR-205 in entinostat-induced downregulation of erbB2/erbB3 and apoptosis in breast cancer cells.
Wang S; Huang J; Lyu H; Lee CK; Tan J; Wang J; Liu B
Cell Death Dis; 2013 Mar; 4(3):e556. PubMed ID: 23519125
[TBL] [Abstract][Full Text] [Related]
8. Nectin-like molecule-4/cell adhesion molecule 4 inhibits the ligand-induced dimerization of ErbB3 with ErbB2.
Mizutani K; Kedashiro S; Maruoka M; Ueda Y; Takai Y
Sci Rep; 2017 Sep; 7(1):11375. PubMed ID: 28900130
[TBL] [Abstract][Full Text] [Related]
9. Pertuzumab counteracts the inhibitory effect of ErbB2 on degradation of ErbB3.
Sak MM; Szymanska M; Bertelsen V; Hasmann M; Madshus IH; Stang E
Carcinogenesis; 2013 Sep; 34(9):2031-8. PubMed ID: 23698633
[TBL] [Abstract][Full Text] [Related]
10. Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.
Lund CV; Popkov M; Magnenat L; Barbas CF
Mol Cell Biol; 2005 Oct; 25(20):9082-91. PubMed ID: 16199884
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of the tumor-suppressor cell adhesion molecule 1 in human papillomavirus-transformed cervical carcinoma cells.
Woo HJ; Kim SJ; Song KJ; Kim SS; Yoon CH; Choi BS; Rhee JE
Int J Oncol; 2015; 46(6):2656-62. PubMed ID: 25845528
[TBL] [Abstract][Full Text] [Related]
14. Regulation of platelet-derived growth factor-induced Ras signaling by poliovirus receptor Necl-5 and negative growth regulator Sprouty2.
Kajita M; Ikeda W; Tamaru Y; Takai Y
Genes Cells; 2007 Mar; 12(3):345-57. PubMed ID: 17352739
[TBL] [Abstract][Full Text] [Related]
15. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
[TBL] [Abstract][Full Text] [Related]
16. EGF receptor inhibitors increase ErbB3 mRNA and protein levels in breast cancer cells.
Grøvdal LM; Kim J; Holst MR; Knudsen SL; Grandal MV; van Deurs B
Cell Signal; 2012 Jan; 24(1):296-301. PubMed ID: 21951604
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.
Yang Z; Wang R; Zhang T; Dong X
Int J Clin Exp Pathol; 2015; 8(8):8869-80. PubMed ID: 26464628
[TBL] [Abstract][Full Text] [Related]
18. MYCN-mediated miR-21 overexpression enhances chemo-resistance via targeting CADM1 in tongue cancer.
Zheng G; Li N; Jia X; Peng C; Luo L; Deng Y; Yin J; Song Y; Liu H; Lu M; Zhang Z; Gu Y; He Z
J Mol Med (Berl); 2016 Oct; 94(10):1129-1141. PubMed ID: 27055844
[TBL] [Abstract][Full Text] [Related]
19. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
20. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
